Analytical Data
-
基因名
S100A7L2
- Application
-
别名
S100A7L2; S100A7B; Protein S100-A7-like 2; S100 calcium-binding protein A7-like 2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q5SY68
-
表达区间
1-101 aa
-
氨基酸序列
MNIPLGEKVM LDIVAMFRQY SGDDGRMDMP GLVNLMKENF PNFLSGCEKS DMDYLSNALE KKDDNKDKKV NYSEFLSLLG DITIDHHKIM HGVAPCSGGS Q
-
分子量
11.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
S100A7L2, a member of the S100 protein family, is characterized by its EF-hand type calcium-binding motifs and is primarily expressed in epithelial tissues. Its role has emerged as significant in various biological processes, including cellular growth, differentiation, and inflammation. Research indicates that S100A7L2 may be involved in the pathogenesis of several diseases, including cancer, due to its regulatory impact on cell signaling pathways and immune responses. Recent studies have highlighted its potential as a biomarker for certain conditions and a target for therapeutic interventions. The recombinant protein of S100A7L2 has been generated to facilitate in-depth studies on its biological functions, interactions, and mechanisms of action. Understanding the properties and roles of S100A7L2 in health and disease could provide valuable insights into potential diagnostic and therapeutic strategies, warranting further investigation in both basic and clinical research settings.
